A well-known class of drugs used to manage type 2 diabetes and control weight could offer hope for patients who also struggle ...

GLP-1 medications are renowned for their ability to treat type 2 diabetes and aid weight loss. Now, there's a new benefit to ...

Learn how chronic kidney disease and diabetes accelerate heart risk, with new research revealing early warning signs.

Compared to another common class of kidney medications, called DPP4is, GLP1-RA medications did better in helping slow the ...

Chronic kidney disease (CKD) is a progressive renal disease that causes kidney function to deteriorate. It appears as urinary ...

Denmark: A recent study published in the Journal of Diabetes and its Complications has explored the role of kidney fat ...

The Food and Drug Administration has approved Ozempic ® (semaglutide) to reduce the risk of sustained estimated glomerular ...

Though highly effective, medications for the prevention of chronic kidney disease progression are under-utilized, emphasizing the need for better use of prognostic tools.

The discontinuation comes after the investigational drug, volenrelaxin, failed a related heart failure study in an ...

Nephrologists jumped on the GLP-1 bandwagon well before Novo Nordisk won FDA approval for Ozempic in chronic kidney disease ...

Adults in Tanzania living with HIV and taking tenofovir have a higher rate of chronic kidney disease vs. those without the ...

Chandigarh: Noting that the denial of the claim for medical reimbursement on the ground that it was taken in OPD, is not ...